UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A 0.7 V, 23 GHz, low cost BiCMOS amplifier with 2.8 mW power consumption

2006 European Conference on Wireless Technology, 2006, p.71-74

2006

Volltextzugriff (PDF)

0008 SUVN-G3031, A Histamine H3 Receptor Inverse Agonist Produces Robust Wake Promoting and Anticataplectic Activity in Orexin Knockout Mice

Sleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A3-A3

2020

Volltextzugriff (PDF)

0026 - An NIHR Approved Two-Year Observational Study on Magnetically Controlled Growth Rods

The spine journal, 2017-11, Vol.17 (11), p.S323-S323

2017

Volltextzugriff (PDF)

004 Samelisant (SUVN-G3031), Differentiating features over current treatments of narcolepsy

Sleep (New York, N.Y.), 2021-05, Vol.44 (Supplement_2), p.A2-A2

2021

Volltextzugriff (PDF)

0045 - The Oxford Five-Year Observational Study of 35 Patients With Magnetically Controlled Growing Rods

The spine journal, 2017-11, Vol.17 (11), p.S327-S327

2017

Volltextzugriff (PDF)

0046 - Quantifying the “Law of Diminishing Returns” in Magnetically Controlled Growing Rods

The spine journal, 2017-11, Vol.17 (11), p.S328-S328

2017

Volltextzugriff (PDF)

0051 Samelisant, a H3 Receptor Inverse Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Parkinson’s Disease

Sleep (New York, N.Y.), 2023-05, Vol.46 (Supplement_1), p.A23-A25

2023

Volltextzugriff (PDF)

0054 SUVN-G3031, a Histamine H3 Receptor Inverse Agonist Produces Wake Promoting Effect in Orexin-2-saporin Lesioned Rats

Sleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A22-A23

2019

Volltextzugriff (PDF)

0072 Preclinical Characterization of SUVN-G3031, a Histamine H3 Receptor Inverse Agonist for the Treatment of Narcolepsy

Sleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A29-A29

2020

Volltextzugriff (PDF)

0139 SUVN-G3031, A Potent and Selective Histamine H3 Receptor Inverse Agonist - Phase-2 Investigational New Drug for the Treatment of Narcolepsy - Differentiating Factors with Competitor Clinical Candidates

Sleep (New York, N.Y.), 2019-04, Vol.42 (Supplement_1), p.A57-A57

2019

Volltextzugriff (PDF)

0155 SUVN-G3031, A Potent and Selective Histamine H3 Receptor Inverse Agonist - Differentiating Features Over Current Treatments of Narcolepsy

Sleep (New York, N.Y.), 2020-05, Vol.43 (Supplement_1), p.A61-A61

2020

Volltextzugriff (PDF)

0615 Thermo-Mechanical Fatigue Failure of Thermal Barrier Coatings on the Ni-based Superalloy

The Proceedings of Conference of Hokuriku-Shinetsu Branch, 2012-03, Vol.2012.49, p.61501-61502

2012

Volltextzugriff (PDF)

0649 Samelisant Improves the Symptoms of Excessive Daytime Sleepiness in Narcolepsy: Results from a Phase-2 Study

Sleep (New York, N.Y.), 2024-04, Vol.47 (Supplement_1), p.A277-A278

2024

Volltextzugriff (PDF)

075 Anxiety and depression in women with idiopathic intracranial hypertension: a matched controlled retrospective cohort study

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (9), p.e2

2022

Volltextzugriff (PDF)

077 Opiate and headache prescribing patterns in idiopathic intracranial hyperten- sion: a matched controlled retrospective cohort study

Journal of neurology, neurosurgery and psychiatry, 2022-09, Vol.93 (9), p.e2

2022

Volltextzugriff (PDF)

081 Lymphoma: a great imitator in neurology and its many faces

Journal of neurology, neurosurgery and psychiatry, 2019-07, Vol.90 (e7), p.A26-A26

2019

Volltextzugriff (PDF)

094 Vascular targeting of phosphatidylserine causing thrombotic occlusion in an arteriovenous malformation animal model

Journal of neurology, neurosurgery and psychiatry, 2018-06, Vol.89 (6), p.A37-A38

2018

Volltextzugriff (PDF)

1: CORRELATION OF CHADS2 WITH NEW ONSET ATRIAL FIBRILLATION IN THORACIC AND VASCULAR SURGICAL PATIENTS

Critical care medicine, 2014-12, Vol.42, p.A1369

2014

Volltextzugriff (PDF)

[1,2,4]triazolo[1,5- c ]quinazolin-2(3 H )-ones and their thio analogues: a one pot synthesis† 1

Journal of chemical research, 2002-10, Vol.2002 (10), p.490-492

2002

Volltextzugriff (PDF)

[1,2,4]Triazolo[1,5-c]quinazolin-2(3H)-ones and Their Thio Analogues: A One Pot Synthesis

ChemInform, 2003-04, Vol.34 (15), p.no-no

2003

Volltextzugriff (PDF)

1,2-Bis(2,6-diethylphenyl)-3,3-(oxydiethyl)guanidine

Acta crystallographica. Section C, Crystal structure communications, 1997-01, Vol.53 (1), p.88-90

1997

Volltextzugriff (PDF)

1, 2-Diboretanide: homoaromatische 2π-Elektronen-Verbindungen mit hohen Inversionsbarrieren

Angewandte Chemie, 1996-09, Vol.108 (17), p.2123-2125

1996

Volltextzugriff (PDF)

1, 2‐Diboretanide: homoaromatische 2π‐Elektronen‐Verbindungen mit hohen Inversionsbarrieren

Angewandte Chemie, 1996-09, Vol.108 (17), p.2123-2125

1996

Volltextzugriff (PDF)

1,2-Diboretanides: Homoaromatic 2π-Electron Compounds with High Inversion Barriers

Angewandte Chemie (International ed.), 1996-09, Vol.35 (17), p.1990-1992

1996

Volltextzugriff (PDF)

1 – 25 von 49.125

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33.775)
Mit Volltextzugriff
(39.600)

Publikationsform

8 weitere anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(24.058)
Life Sciences & Biomedicine
(11.846)
Technology
(8.278)
Physical Sciences
(6.958)
Humans
(6.231)
Chemistry
(3.855)
Engineering
(3.817)
Materials Science
(3.160)
Male
(3.130)
Female
(2.993)
Animals
(2.814)
Physics
(2.673)
Exact Sciences And Technology
(2.567)
Biological And Medical Sciences
(2.103)
Science & Technology - Other Topics
(2.088)
Materials Science, Multidisciplinary
(2.035)
Computer Science
(1.975)
Biochemistry & Molecular Biology
(1.619)
Adult
(1.618)
Middle Aged
(1.545)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ingenta
(16.462)
Regensburg "Free" Collection
(15.332)
MEDLINE
(9.366)
Elsevier ScienceDirect Journals Complete
(7.935)
Journals@Ovid Full Text
(7.694)
IngentaConnect Journals
(6.656)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(4.891)
Single Journals
(4.797)
Ebook Central Perpetual and DDA
(4.335)
eBooks on EBSCOhost
(4.231)
Wiley-Blackwell Full Collection
(4.104)
Springer Nature - Complete Springer Journals
(3.909)
IEEE Xplore
(2.969)
Wiley Online Library
(2.535)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(2.392)
Jstor Complete Legacy
(1.539)
Taylor & Francis Online
(1.480)
Taylor & Francis Current Content Access
(1.478)
Taylor & Francis Journals Auto-Holdings Collection
(1.400)
EBSCOhost Business Source Ultimate
(1.205)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(338)
Meeting Abstracts
(315)
Cheminform
(299)
Business Today
(289)
Current Science
(282)
Ssrn Electronic Journal
(266)
Journal Of Hepatology
(257)
The Journal Of Biological Chemistry
(215)
Gastroenterology
(212)
Madras Agricultural Journal
(189)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(778)
... seit 30 Tagen
(175)

Menü

Weitere Dienste

Einstellungen

A 0.7 V, 23 GHz, low cost BiCMOS amplifier with 2.8 mW power consumption

0008 SUVN-G3031, A Histamine H3 Receptor Inverse Agonist Produces Robust Wake Promoting and Anticataplectic Activity in Orexin Knockout Mice

0026 - An NIHR Approved Two-Year Observational Study on Magnetically Controlled Growth Rods

004 Samelisant (SUVN-G3031), Differentiating features over current treatments of narcolepsy

0045 - The Oxford Five-Year Observational Study of 35 Patients With Magnetically Controlled Growing Rods

0046 - Quantifying the “Law of Diminishing Returns” in Magnetically Controlled Growing Rods

0051 Samelisant, a H3 Receptor Inverse Agonist for the Potential Treatment of Excessive Daytime Sleepiness in Parkinson’s Disease

0054 SUVN-G3031, a Histamine H3 Receptor Inverse Agonist Produces Wake Promoting Effect in Orexin-2-saporin Lesioned Rats

0072 Preclinical Characterization of SUVN-G3031, a Histamine H3 Receptor Inverse Agonist for the Treatment of Narcolepsy

0139 SUVN-G3031, A Potent and Selective Histamine H3 Receptor Inverse Agonist - Phase-2 Investigational New Drug for the Treatment of Narcolepsy - Differentiating Factors with Competitor Clinical Candidates

0155 SUVN-G3031, A Potent and Selective Histamine H3 Receptor Inverse Agonist - Differentiating Features Over Current Treatments of Narcolepsy

0615 Thermo-Mechanical Fatigue Failure of Thermal Barrier Coatings on the Ni-based Superalloy

0649 Samelisant Improves the Symptoms of Excessive Daytime Sleepiness in Narcolepsy: Results from a Phase-2 Study

075 Anxiety and depression in women with idiopathic intracranial hypertension: a matched controlled retrospective cohort study

077 Opiate and headache prescribing patterns in idiopathic intracranial hyperten- sion: a matched controlled retrospective cohort study

081 Lymphoma: a great imitator in neurology and its many faces

094 Vascular targeting of phosphatidylserine causing thrombotic occlusion in an arteriovenous malformation animal model

1: CORRELATION OF CHADS2 WITH NEW ONSET ATRIAL FIBRILLATION IN THORACIC AND VASCULAR SURGICAL PATIENTS

1-[2-(1-Cyclobutylpiperidin-4-yloxy)-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl]propan-1-one: a Histamine H 3 Receptor Inverse Agonist with Efficacy in Animal Models of Cognition

[1,2,4]triazolo[1,5- c ]quinazolin-2(3 H )-ones and their thio analogues: a one pot synthesis† 1

[1,2,4]Triazolo[1,5-c]quinazolin-2(3H)-ones and Their Thio Analogues: A One Pot Synthesis

1,2-Bis(2,6-diethylphenyl)-3,3-(oxydiethyl)guanidine

1, 2-Diboretanide: homoaromatische 2π-Elektronen-Verbindungen mit hohen Inversionsbarrieren

1, 2‐Diboretanide: homoaromatische 2π‐Elektronen‐Verbindungen mit hohen Inversionsbarrieren

1,2-Diboretanides: Homoaromatic 2π-Electron Compounds with High Inversion Barriers

Suchergebnisse filtern